Cargando…

Mobile Phone–Based Telemedicine Practice in Older Chinese Patients with Type 2 Diabetes Mellitus: Randomized Controlled Trial

BACKGROUND: Previous studies on telemedicine interventions have shown that older diabetic patients experience difficulty in using computers, which is a barrier to remote communication between medical teams and older diabetic patients. However, older people in China tend to find it easy to use mobile...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Chenglin, Sun, Lin, Xi, Shugang, Zhang, Hong, Wang, Huan, Feng, Yakun, Deng, Yufeng, Wang, Haimin, Xiao, Xianchao, Wang, Gang, Gao, Yuan, Wang, Guixia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682265/
https://www.ncbi.nlm.nih.gov/pubmed/30609983
http://dx.doi.org/10.2196/10664
_version_ 1783441862114148352
author Sun, Chenglin
Sun, Lin
Xi, Shugang
Zhang, Hong
Wang, Huan
Feng, Yakun
Deng, Yufeng
Wang, Haimin
Xiao, Xianchao
Wang, Gang
Gao, Yuan
Wang, Guixia
author_facet Sun, Chenglin
Sun, Lin
Xi, Shugang
Zhang, Hong
Wang, Huan
Feng, Yakun
Deng, Yufeng
Wang, Haimin
Xiao, Xianchao
Wang, Gang
Gao, Yuan
Wang, Guixia
author_sort Sun, Chenglin
collection PubMed
description BACKGROUND: Previous studies on telemedicine interventions have shown that older diabetic patients experience difficulty in using computers, which is a barrier to remote communication between medical teams and older diabetic patients. However, older people in China tend to find it easy to use mobile phones and personal messaging apps that have a user-friendly interface. Therefore, we designed a mobile health (mHealth) system for older people with diabetes that is based on mobile phones, has a streamlined operation interface, and incorporates maximum automation. OBJECTIVE: The goal of the research was to investigate the use of mobile phone–based telemedicine apps for management of older Chinese patients with type 2 diabetes mellitus (T2DM). Variables of interest included efficacy and safety. METHODS: A total of 91 older (aged over 65 years) patients with T2DM who presented to our department were randomly assigned to one of two groups. Patients in the intervention group (n=44) were provided glucometers capable of data transmission and received advice pertaining to medication, diet, and exercise via the mHealth telemedicine system. Patients assigned to the control group (n=47) received routine outpatient care with no additional intervention. Patients in both groups were followed up at regular 3-month intervals. RESULTS: After 3 months, patients in the intervention group showed significant (P<.05) improvement in postprandial plasma glucose level. After 6 months, patients in the intervention group exhibited a decreasing trend in postprandial plasma glucose and glycated hemoglobin levels compared with the baseline and those in the control group (P<.05). CONCLUSIONS: Mobile phone–based telemedicine apps help improve glycemic control in older Chinese patients with T2DM. TRIAL REGISTRATION: China Clinical Trial Registration Center ChiCTR 1800015214; http://www.chictr.org.cn/showprojen.aspx?proj=25949 (Archived by WebCite at http://www.webcitation.org/73wKj1GMq).
format Online
Article
Text
id pubmed-6682265
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-66822652019-09-23 Mobile Phone–Based Telemedicine Practice in Older Chinese Patients with Type 2 Diabetes Mellitus: Randomized Controlled Trial Sun, Chenglin Sun, Lin Xi, Shugang Zhang, Hong Wang, Huan Feng, Yakun Deng, Yufeng Wang, Haimin Xiao, Xianchao Wang, Gang Gao, Yuan Wang, Guixia JMIR Mhealth Uhealth Original Paper BACKGROUND: Previous studies on telemedicine interventions have shown that older diabetic patients experience difficulty in using computers, which is a barrier to remote communication between medical teams and older diabetic patients. However, older people in China tend to find it easy to use mobile phones and personal messaging apps that have a user-friendly interface. Therefore, we designed a mobile health (mHealth) system for older people with diabetes that is based on mobile phones, has a streamlined operation interface, and incorporates maximum automation. OBJECTIVE: The goal of the research was to investigate the use of mobile phone–based telemedicine apps for management of older Chinese patients with type 2 diabetes mellitus (T2DM). Variables of interest included efficacy and safety. METHODS: A total of 91 older (aged over 65 years) patients with T2DM who presented to our department were randomly assigned to one of two groups. Patients in the intervention group (n=44) were provided glucometers capable of data transmission and received advice pertaining to medication, diet, and exercise via the mHealth telemedicine system. Patients assigned to the control group (n=47) received routine outpatient care with no additional intervention. Patients in both groups were followed up at regular 3-month intervals. RESULTS: After 3 months, patients in the intervention group showed significant (P<.05) improvement in postprandial plasma glucose level. After 6 months, patients in the intervention group exhibited a decreasing trend in postprandial plasma glucose and glycated hemoglobin levels compared with the baseline and those in the control group (P<.05). CONCLUSIONS: Mobile phone–based telemedicine apps help improve glycemic control in older Chinese patients with T2DM. TRIAL REGISTRATION: China Clinical Trial Registration Center ChiCTR 1800015214; http://www.chictr.org.cn/showprojen.aspx?proj=25949 (Archived by WebCite at http://www.webcitation.org/73wKj1GMq). JMIR Publications 2019-01-04 /pmc/articles/PMC6682265/ /pubmed/30609983 http://dx.doi.org/10.2196/10664 Text en ©Chenglin Sun, Lin Sun, Shugang Xi, Hong Zhang, Huan Wang, Yakun Feng, Yufeng Deng, Haimin Wang, Xianchao Xiao, Gang Wang, Yuan Gao, Guixia Wang. Originally published in JMIR Mhealth and Uhealth (http://mhealth.jmir.org), 04.01.2019. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR mhealth and uhealth, is properly cited. The complete bibliographic information, a link to the original publication on http://mhealth.jmir.org/, as well as this copyright and license information must be included.
spellingShingle Original Paper
Sun, Chenglin
Sun, Lin
Xi, Shugang
Zhang, Hong
Wang, Huan
Feng, Yakun
Deng, Yufeng
Wang, Haimin
Xiao, Xianchao
Wang, Gang
Gao, Yuan
Wang, Guixia
Mobile Phone–Based Telemedicine Practice in Older Chinese Patients with Type 2 Diabetes Mellitus: Randomized Controlled Trial
title Mobile Phone–Based Telemedicine Practice in Older Chinese Patients with Type 2 Diabetes Mellitus: Randomized Controlled Trial
title_full Mobile Phone–Based Telemedicine Practice in Older Chinese Patients with Type 2 Diabetes Mellitus: Randomized Controlled Trial
title_fullStr Mobile Phone–Based Telemedicine Practice in Older Chinese Patients with Type 2 Diabetes Mellitus: Randomized Controlled Trial
title_full_unstemmed Mobile Phone–Based Telemedicine Practice in Older Chinese Patients with Type 2 Diabetes Mellitus: Randomized Controlled Trial
title_short Mobile Phone–Based Telemedicine Practice in Older Chinese Patients with Type 2 Diabetes Mellitus: Randomized Controlled Trial
title_sort mobile phone–based telemedicine practice in older chinese patients with type 2 diabetes mellitus: randomized controlled trial
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682265/
https://www.ncbi.nlm.nih.gov/pubmed/30609983
http://dx.doi.org/10.2196/10664
work_keys_str_mv AT sunchenglin mobilephonebasedtelemedicinepracticeinolderchinesepatientswithtype2diabetesmellitusrandomizedcontrolledtrial
AT sunlin mobilephonebasedtelemedicinepracticeinolderchinesepatientswithtype2diabetesmellitusrandomizedcontrolledtrial
AT xishugang mobilephonebasedtelemedicinepracticeinolderchinesepatientswithtype2diabetesmellitusrandomizedcontrolledtrial
AT zhanghong mobilephonebasedtelemedicinepracticeinolderchinesepatientswithtype2diabetesmellitusrandomizedcontrolledtrial
AT wanghuan mobilephonebasedtelemedicinepracticeinolderchinesepatientswithtype2diabetesmellitusrandomizedcontrolledtrial
AT fengyakun mobilephonebasedtelemedicinepracticeinolderchinesepatientswithtype2diabetesmellitusrandomizedcontrolledtrial
AT dengyufeng mobilephonebasedtelemedicinepracticeinolderchinesepatientswithtype2diabetesmellitusrandomizedcontrolledtrial
AT wanghaimin mobilephonebasedtelemedicinepracticeinolderchinesepatientswithtype2diabetesmellitusrandomizedcontrolledtrial
AT xiaoxianchao mobilephonebasedtelemedicinepracticeinolderchinesepatientswithtype2diabetesmellitusrandomizedcontrolledtrial
AT wanggang mobilephonebasedtelemedicinepracticeinolderchinesepatientswithtype2diabetesmellitusrandomizedcontrolledtrial
AT gaoyuan mobilephonebasedtelemedicinepracticeinolderchinesepatientswithtype2diabetesmellitusrandomizedcontrolledtrial
AT wangguixia mobilephonebasedtelemedicinepracticeinolderchinesepatientswithtype2diabetesmellitusrandomizedcontrolledtrial